Cargando…
Advances in the Management of Patients With Urothelial Carcinomas of the Bladder
For more than 30 years, there were no new treatments in bladder cancer. Then, in 2016, there were five drug approvals. JADPRO Live presenters delved into recent advancements and opportunities for improving outcomes for patients with bladder cancer.
Autores principales: | Shah, Amishi, Lemke, Emily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333559/ |
Ejemplares similares
-
Management of Advanced Bladder Cancer: An Update
por: Lemke, Emily A., et al.
Publicado: (2018) -
Improving Outcomes for Patients With Advanced Urothelial Carcinoma
por: Grivas, Petros, et al.
Publicado: (2020) -
Bladder extramedullary plasmacytoma and synchronous bladder urothelial transitional cell carcinoma: A case report and review of the literature
por: Wadhwa, Karan, et al.
Publicado: (2011) -
Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021) -
Nested variant of urothelial carcinoma of the urinary bladder
por: Terada, Tadashi
Publicado: (2011)